Aug 5, 2026

In this episode, Gabe Scott, Natalia Nino, and Darrell White discuss the Drug Supply Chain Security Act following the FDA's warning letter to a medical spa over Botox products. Their conversation explores what the enforcement action reveals about the agency's compliance expectations, what it may signal about the F

Jun 23, 2026

In this episode, Gabe Scott, Kevin Alonso, and Cindy Laura Ortega Ramos unpack recent updates to the federal independent dispute resolution (IDR) process under the No Surprises Act. They discuss the operational changes introduced in May by the Departments of Health and Human Services, Labor, and the Treasury, along with...

May 26, 2026

In this episode, Gabe Scott, Sarah Carlins, and Myia Pretty discuss two significant proposed HIPAA rulemakings, including updates to the HIPAA Security Rule and proposed modifications to the HIPAA Privacy Rule. They outline the key policy changes and their underlying rationale, as well as what stakeholders should watch...

May 19, 2026

In this episode, Limo Cherian and Nora Becerra focus on key issues faced by in-house counsel and compliance teams as they address attorney-client privilege concerns. Their discussion focuses on the complexities of privilege that arise during healthcare investigations, specifically those involving fraud and abuse.

Apr 20, 2026

In this episode, Limo Cherian, Andy Ruskin, and Sarah Staples-Carlton unpack the Consolidated Appropriations Act of 2026 and its impact on provider-based clinics. They explain what provider-based status means, why mandatory attestations are back, and what hospitals and health systems must do to stay compliant...